Psychopharmacology and Psychiatry Updates

Podcast autorstwa Psychopharmacology Institute

Kategorie:

265 Odcinki

  1. Tips for Treating Schizophrenia in Children and Adolescents

    Opublikowany: 2.01.2023
  2. Physical Activity to Prevent Depression

    Opublikowany: 28.12.2022
  3. Use of Antipsychotics for Treating Psychosis in Children and Adolescents

    Opublikowany: 23.12.2022
  4. Depression in Adolescents

    Opublikowany: 18.12.2022
  5. Diagnostic Evaluation of Psychotic Symptoms in Children and Adolescents

    Opublikowany: 13.12.2022
  6. Use of Folate and Its Derivatives in Depression

    Opublikowany: 8.12.2022
  7. Antipsychotics and Cholinesterase Inhibitors for BPSD

    Opublikowany: 3.12.2022
  8. SGAs in Youth With Bipolar Depression

    Opublikowany: 28.11.2022
  9. Pharmacologic Treatments for BPSD

    Opublikowany: 23.11.2022
  10. Association Between FIASMA Psychotropics and COVID-19

    Opublikowany: 18.11.2022
  11. Treatment Approaches for BPSD

    Opublikowany: 13.11.2022
  12. Brexpiprazole for Borderline Personality Disorder

    Opublikowany: 8.11.2022
  13. Patient, Caregiver, and Environmental Factors Underlying BPSD

    Opublikowany: 3.11.2022
  14. Long-Term Treatment With Methylphenidate in Preschool Children

    Opublikowany: 29.10.2022
  15. Use of Psychotropics in Patients With Hepatic Issues

    Opublikowany: 24.10.2022
  16. Important Considerations for Switching to Clozapine

    Opublikowany: 19.10.2022
  17. Pharmacologic and Psychosocial Interventions for Reducing Irritability in Youth With ADHD

    Opublikowany: 14.10.2022
  18. Switching From Oral Antipsychotics to LAIs

    Opublikowany: 9.10.2022
  19. Medications for Rapid Tranquilization of Agitated Patients

    Opublikowany: 4.10.2022
  20. Strategies for Antipsychotic Switching

    Opublikowany: 29.09.2022

9 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site